About Technology Issues FAQ

Links

Daratumumab monotherapy in patients with treatment-refractory multiple myeloma (SIRIUS): an open-label, randomised, phase 2 trial

Daratumumab monotherapy in patients with treatment-refractory multiple myeloma (SIRIUS): an open-label, randomised, phase 2 trial — Distribution of the number of citations over years.

site/software © exaly; All materials licenced under CC by-SA.